Ascend Laboratories Recalls Two Levoneptin Batches
The health authority issued a precautionary recall following the discovery of impurities in two specific medication batches.
Updated on Oct. 30, 2026 in Asthma
Live Poll
Do you feel confident in your ability to identify if your medication is part of a recall?
Ascend Laboratories has initiated a voluntary recall for two batches of Levoneptin after routine testing revealed impurity levels exceeding safety limits. The South African Health Products Regulatory Authority has formalised the notice, requiring all distributors to stop dispensing the affected medication.
Why it matters
The recall serves as a safety measure to ensure patients do not consume medication that may fail to meet quality standards due to potential deterioration. By isolating these batches, health officials aim to prevent the distribution of ineffective or compromised pharmaceutical products.
The recall affects batches 24142840 and 24142842, which contain 100 capsules per blister pack and have an expiration date of June 2027. These specific lots were first introduced to the South African market in December 2024.
The players
Ascend Laboratories
This is the pharmaceutical manufacturer responsible for producing Levoneptin and issuing the voluntary recall.
South African Health Products Regulatory Authority
This is the national regulatory body that oversees the safety, quality, and efficacy of medicines available in South Africa.
DP World Healthcare Logistics
This is the logistics provider tasked with the collection and handling of the recalled pharmaceutical stock.
The details
Healthcare professionals are instructed to immediately quarantine any stock belonging to the impacted batches and facilitate returns via DP World Healthcare Logistics. The action is classified as a Class II Type B recall, indicating that the product may pose a health risk if used.
Timeline
December 2024: The Levoneptin batches were first distributed.
22 October 2026: Ascend Laboratories initiated the recall.
27 October 2026: The South African Health Products Regulatory Authority published the official recall notice.
June 2027: The expiration date for the affected batches.
The Big Picture
This recall reflects the rigorous oversight mandated by the Medicines and Related Substances Act to maintain high quality standards in the pharmaceutical supply chain. Such actions follow a established pattern of regulatory intervention used to protect public health when quality thresholds are not met.
Patients currently in possession of Levoneptin should verify their batch numbers against 24142840 and 24142842 to ensure they are not using compromised medication. You should consult your pharmacist or healthcare provider immediately to arrange for a safe replacement if your supply is part of the recall.
The takeaway
Always check the batch number on your medication packaging against official recall lists if you are notified of a potential quality issue. Patients are encouraged to keep their pharmacies updated with current contact details to ensure they receive urgent health warnings promptly.
Further reading
For more information on respiratory health and medication safety, visit the Asthma section.
Source note: This article includes information reported by The Citizen.
Live Poll
Do you feel confident in your ability to identify if your medication is part of a recall?
